Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-25 17:58 CEST (UTC+2h)

A conference invitation that I got today [Off Topic]

posted by ElMaestro - Denmark, 2018-06-06 13:39  - Posting: # 18856
Views: 584

"Dear (ElMaestro)

It is our great pleasure and privilege to welcome you to join the 7thAnnual World Congress of Food and Nutrition-2018(WCFN-2018), which will be held during November 13-15, 2018 in Singapore. On behalf of the Organizing Committee, we would be honored to invite you to be a chair/speaker at Session 103: Regional Food Cultures Practices and Nutrition Education while presenting about Approval of Generic Fluticasone Propionate/Salmeterol Xinafoate Dry Powder Inhalers in the US: A Difficult Exercise in Regulatory Science at the upcoming WCFN-2018."

I am no expert, in fact I believe I am a person with a completely unqualified opinion about many things including pharmaceuticals. Having been a frequent traveler in the US and in possession of an enormously fat and ill-maintained body I even have a strong opinion about (lack of) food culture and nutrition, but I have no idea -and I mean that literally- how the f%ck anyone can even remotely think it relevant to talk about Fluticasone/Salmeterol inhalers at a food & nutrition conference.

Wishing you all a good day.

if (3) 4

Best regards,

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,428 posts in 3,913 threads, 1,176 registered users;
online 26 (0 registered, 26 guests [including 20 identified bots]).

Lack of clarity is always a sign of dishonesty.    Celia Green

BEBAC Ing. Helmut Schütz